Physical Biochemistry and Biology of Amyloid Beta-Protein
Physical Biochemistry and Biology of Amyloid Beta-Protein
批准号:
8850772
负责人:
DAVID B. TEPLOW
金额:
$30.62万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-15 至 2016-05-31
关键词:
Alzheimer&aposs DiseaseAmyloidAmyloid beta-ProteinBiochemistryBioinformaticsBiologicalBiologyCell LineCerealsCircular DichroismCountryDevelopmentDiseaseDrosophila eyeEye DevelopmentFluorescenceFoundationsGenesGoalsHumanHydroxyl RadicalIn VitroLeadLifeLight-Scattering SpectroscopyLocomotionLongevityMass Spectrum AnalysisModelingMolecular ConformationMutagenesisNeuronsNeurotoxinsPathologicPeptidesPrintingProtein FragmentProteinsProteolysisResearchResolutionScanningSeedsSeminalSolventsSpectrum AnalysisStructureStructure-Activity RelationshipSystemTherapeuticTherapeutic AgentsThioflavin TTimeTissue-Specific Gene ExpressionUnited StatesWorkagedbiophysical analysiscrosslinkcytotoxicfootin vivoinsightion mobilitymolecular dynamicsmultidisciplinaryneurotoxicnovelpreventprotein oligomerresearch clinical testingsenescencestructural biologytau Proteins
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is a devastating disease of the aged. Two amyloid-forming proteins are associated with AD, the amyloidß-protein (Aß) and tau. Recent evidence supports an hypothesis, the "amyloid cascade hypothesis," that posits that Aß oligomers are the seminal neuropathogenetic agents in AD. The overall goal of this proposal is to understand the structural biology of Aß, and fragments thereof, and to establish formal structure-activity relationships. In the long run, we seek to obtain an atomic-resolution determination of the structure of the proximate neurotoxins formed by Aß, and in doing so, enable the development, for the first time, of disease-modifying AD treatments. A multidisciplinary strategy, employing complementary experimental and computational approaches, will be employed. This strategy has been used very successfully in the past, providing novel insights into the Aß system. Three specific aims are proposed that systematically and logically progress from in vitro biophysical studies of Aß and its oligomeric assemblies (Aim 1), to in vitro and in vivo studies of the biological activity of selected such assemblies (Aim 2), to determination of the effects of selected assemblies on differential gene expression in neurons (Aim 3). Taken together, these studies will provide the theoretical and experimental foundation for subsequent therapeutic compound development and clinical testing in humans. Aim 1. To determine the structural dynamics of Aß and tau assembly. a. To use scanning Tyr mutagenesis to elucidate mechanisms of Aß oligomerization. b. To determine the dynamics of intramolecular turn formation and its effects on Aß assembly. c. To determine the effects of primary structure changes on the conformations and assembly dynamics of biologically relevant and theoretically important Aß peptides. Aim 2. To determine the biological effects of Aß assemblies. a. To determine the cytotoxic effects of Aß assemblies on cultured neuronal cell lines and primary neurons. b. To determine the effects of Aß assemblies on Drosophila eye development, locomotion, and longevity. Aim 3. To identify and validate AD-relevant genes using a bioinformatics approach that considers Aß assembly structure, neuron type, and neuron senescence.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1021/acschemneuro.5b00171
发表时间:
2015-10-21
期刊:
ACS chemical neuroscience
影响因子:
5
作者:
[Zheng X, Liu D, Roychaudhuri R, Teplow DB, Bowers MT]
通讯作者:
Bowers MT
Physical Biochemistry and Biology of Amyloid Beta-Protein
-
批准号:8332301
-
项目类别:
-
资助金额:$31.57万
-
财政年份:2011
-
负责人:DAVID B. TEPLOW
-
依托单位:
Physical Biochemistry and Biology of Amyloid Beta-Protein
-
批准号:8531820
-
项目类别:
-
资助金额:$29.83万
-
财政年份:2011
-
负责人:DAVID B. TEPLOW
-
依托单位:
Physical Biochemistry and Biology of Amyloid Beta-Protein
-
批准号:8222749
-
项目类别:
-
资助金额:$31.57万
-
财政年份:2011
-
负责人:DAVID B. TEPLOW
-
依托单位:
Physical Biochemistry and Biology of Amyloid Beta-Protein
-
批准号:8722423
-
项目类别:
-
资助金额:$31.57万
-
财政年份:2011
-
负责人:DAVID B. TEPLOW
-
依托单位:
SIMULATION OF AMYLOID BETA-PROTEIN FOLDING AND ASSEMBLY
-
批准号:7724408
-
项目类别:
-
资助金额:$0.26万
-
财政年份:2008
-
负责人:DAVID B. TEPLOW
-
依托单位:
SIMULATION OF AMYLOID BETA-PROTEIN FOLDING AND ASSEMBLY
-
批准号:7627780
-
项目类别:
-
资助金额:$2.01万
-
财政年份:2007
-
负责人:DAVID B. TEPLOW
-
依托单位:
Pathologic protein folding and human disease
-
批准号:7663805
-
项目类别:
-
资助金额:$153.53万
-
财政年份:2006
-
负责人:DAVID B. TEPLOW
-
依托单位:
Pathologic protein folding and human disease
-
批准号:7279127
-
项目类别:
-
资助金额:$149.23万
-
财政年份:2006
-
负责人:DAVID B. TEPLOW
-
依托单位:
Pathologic protein folding and human disease
-
批准号:7080008
-
项目类别:
-
资助金额:$154.72万
-
财政年份:2006
-
负责人:DAVID B. TEPLOW
-
依托单位:
PHYSICAL BIOCHEMISTRY AND BIOLOGY OF AMYLOID B-PROTEIN
-
批准号:7112180
-
项目类别:
-
资助金额:$19.74万
-
财政年份:2006
-
负责人:DAVID B. TEPLOW
-
依托单位:
Pathologic protein folding and human disease
-
批准号:7469486
-
项目类别:
-
资助金额:$150.19万
-
财政年份:2006
-
负责人:DAVID B. TEPLOW
-
依托单位:
PROTEIN CHEMISTRY CORE
-
批准号:7112179
-
项目类别:
-
资助金额:$26.67万
-
财政年份:2006
-
负责人:DAVID B. TEPLOW
-
依托单位:
Pathologic protein folding and human disease
-
批准号:7903270
-
项目类别:
-
资助金额:$155.27万
-
财政年份:2006
-
负责人:DAVID B. TEPLOW
-
依托单位:
PROCISE CLC SEQUENCING SYST: MULTIPLE SCLEROSIS, EXPERIMENTAL AUTOIMMUNE ENCEPHA
-
批准号:6973352
-
项目类别:
-
资助金额:$5.53万
-
财政年份:2004
-
负责人:DAVID B. TEPLOW
-
依托单位:
PROCISE CLC SEQUENCING SYST: ALZHEIMER'S DISEASE
-
批准号:6973351
-
项目类别:
-
资助金额:$11.06万
-
财政年份:2004
-
负责人:DAVID B. TEPLOW
-
依托单位:
PROCISE cLC Sequencing System 2 Cart w/PC
-
批准号:6730937
-
项目类别:
-
资助金额:$18.44万
-
财政年份:2004
-
负责人:DAVID B. TEPLOW
-
依托单位:
PROCISE CLC SEQUENCING SYST: OSTEOPOROSIS
-
批准号:6973353
-
项目类别:
-
资助金额:$0.92万
-
财政年份:2004
-
负责人:DAVID B. TEPLOW
-
依托单位:
PROCISE CLC SEQUENCING SYST: PARKINSON'S DISEASE
-
批准号:6973354
-
项目类别:
-
资助金额:$0.92万
-
财政年份:2004
-
负责人:DAVID B. TEPLOW
-
依托单位:
Formation and Function of Prefibrillar ABeta Assemblies
-
批准号:7125471
-
项目类别:
-
资助金额:$46.61万
-
财政年份:2003
-
负责人:DAVID B. TEPLOW
-
依托单位:
Formation and Function of Prefibrillar ABeta Assemblies
-
批准号:7122656
-
项目类别:
-
资助金额:$46.37万
-
财政年份:2003
-
负责人:DAVID B. TEPLOW
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: